1. Home
  2. VNDA vs NATR Comparison

VNDA vs NATR Comparison

Compare VNDA & NATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • NATR
  • Stock Information
  • Founded
  • VNDA 2002
  • NATR 1972
  • Country
  • VNDA United States
  • NATR United States
  • Employees
  • VNDA N/A
  • NATR N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • NATR Biotechnology: Pharmaceutical Preparations
  • Sector
  • VNDA Health Care
  • NATR Health Care
  • Exchange
  • VNDA Nasdaq
  • NATR Nasdaq
  • Market Cap
  • VNDA 249.4M
  • NATR 297.2M
  • IPO Year
  • VNDA 2006
  • NATR N/A
  • Fundamental
  • Price
  • VNDA $4.51
  • NATR $16.96
  • Analyst Decision
  • VNDA Strong Buy
  • NATR Strong Buy
  • Analyst Count
  • VNDA 2
  • NATR 2
  • Target Price
  • VNDA $16.50
  • NATR $20.50
  • AVG Volume (30 Days)
  • VNDA 404.6K
  • NATR 104.7K
  • Earning Date
  • VNDA 11-05-2025
  • NATR 11-06-2025
  • Dividend Yield
  • VNDA N/A
  • NATR N/A
  • EPS Growth
  • VNDA N/A
  • NATR N/A
  • EPS
  • VNDA N/A
  • NATR 0.75
  • Revenue
  • VNDA $203,467,000.00
  • NATR $460,818,000.00
  • Revenue This Year
  • VNDA $15.45
  • NATR $4.88
  • Revenue Next Year
  • VNDA $37.82
  • NATR $2.66
  • P/E Ratio
  • VNDA N/A
  • NATR $22.71
  • Revenue Growth
  • VNDA 11.78
  • NATR 4.33
  • 52 Week Low
  • VNDA $3.81
  • NATR $11.01
  • 52 Week High
  • VNDA $5.55
  • NATR $18.06
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 46.90
  • NATR 57.56
  • Support Level
  • VNDA $4.54
  • NATR $16.75
  • Resistance Level
  • VNDA $4.64
  • NATR $17.37
  • Average True Range (ATR)
  • VNDA 0.15
  • NATR 0.46
  • MACD
  • VNDA -0.01
  • NATR -0.04
  • Stochastic Oscillator
  • VNDA 8.89
  • NATR 54.97

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

About NATR Nature's Sunshine Products Inc.

Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.

Share on Social Networks: